Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women.
As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products.
Solosec is indicated for the treatment of bacterial vaginosis in adult women and trichomoniasis in adults, a common non-viral, curable sexually transmitted infection in the US.
''This partnership will expand the reach of Solosec, allowing more healthcare providers to be aware of its benefits, and increase access for adult women suffering with bacterial vaginosis and adults with trichomoniasis,'' stated Lupin CEO Vinita Gupta.
Singapore Police To Share Key Evidence In Zubeen Garg Case Within 10 Days; Probe On Into Financial Angle & Digital Trails
Samajwadi Party Releases List Of 20 Star Campaigners For Bihar Polls
Pakistan Pulls Out Of Junior Hockey World Cup 2025 In India
Chhattisgarh Govt Transfers Seven IPS Officers In Major Police Reshuffle
(With inputs from PTI)
